Importance of surrogate markers in evaluation of antiviral therapy for HIV infection

被引:13
|
作者
Deyton, L
机构
[1] Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
来源
关键词
D O I
10.1001/jama.276.2.159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:159 / 160
页数:2
相关论文
共 50 条
  • [1] Prognostic markers and surrogate markers of clinical progression in HIV infection
    Churchill, DR
    INTERNATIONAL JOURNAL OF STD & AIDS, 1997, 8 (09) : 552 - 557
  • [2] ANTIVIRAL THERAPY OF HIV-INFECTION
    RICHMAN, DD
    ANNUAL REVIEW OF MEDICINE, 1991, 42 : 69 - 90
  • [3] Surrogate markers for disease progression in treated HIV infection
    Ghani, AC
    de Wolf, F
    Ferguson, NM
    Donnelly, CA
    Coutinho, R
    Miedema, F
    Goudsmit, J
    Anderson, RM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 28 (03) : 226 - 231
  • [4] EPIDEMIOLOGY OF HIV-INFECTION AMONG HEMOPHILIACS AND IMPORTANCE OF CD4+ CELLS AS SURROGATE MARKERS
    CHAISSON, RE
    AIDS PATIENT CARE, 1994, 8 : S3 - S5
  • [5] ANTIVIRAL THERAPY AGAINST HIV-INFECTION
    MITSUYA, H
    YARCHOAN, R
    HAYASHI, S
    BRODER, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 22 (06) : 1282 - 1294
  • [6] Optimal timing of antiviral therapy in HIV infection
    Berman, S. M.
    Journal of Applied Probability, 1994, 31//A
  • [7] Use of Surrogate Versus Clinical Markers in Trials for HIV Infection
    Scott Hammer
    Drug information journal : DIJ / Drug Information Association, 1999, 33 (2): : 347 - 352
  • [8] Use of surrogate versus clinical markers in trials for HIV infection
    Hammer, S
    DRUG INFORMATION JOURNAL, 1999, 33 (02): : 347 - 352
  • [9] OPTIMAL TIMING OF ANTIVIRAL THERAPY IN HIV-INFECTION
    BERMAN, SM
    JOURNAL OF APPLIED PROBABILITY, 1994, 31A : 3 - 15
  • [10] Ups and downs - And ups in the antiviral therapy of HIV infection
    Weller, IVD
    Williams, I
    GENITOURINARY MEDICINE, 1996, 72 (01): : 2 - 5